Understanding dermal scanning.

A reader's guide to the tools clinicians use to image skin... from the dermoscopes dermatologists have carried for decades, to total body photography systems used for high-risk melanoma surveillance, to the newer AI-assisted devices clearing the FDA, and to the aesthetic skin analysis systems you might see in a medical spa. Different tools. Different purposes. It matters which is which.

The spectrum, from medical to aesthetic.

Skin imaging sits on a real spectrum, and where a given tool lives on that spectrum changes what you should expect from it.

On the medical end of the spectrum are tools used to evaluate a lesion that a clinician or a patient is already worried about. A dermatoscope is a handheld magnifier with polarized light that lets a trained eye see structures below the surface of the skin... pigment networks, vascular patterns, regression, and so on.[1][2] Total body photography and sequential digital dermoscopy are used for high-risk patients, often those with many atypical nevi or a personal or family history of melanoma, to track lesions over time so new or changing ones get flagged.[3] Then, a newer category of FDA-cleared AI-assisted devices, like DermaSensor (elastic scattering spectroscopy) and SciBase Nevisense (electrical impedance spectroscopy), provide an objective, device-generated risk signal on a lesion a clinician has already flagged as suspicious.[4][5][6][7][8]

On the aesthetic end of the spectrum are skin analysis systems designed for cosmetic planning. The best-known is VISIA (Canfield Scientific), which uses multi-spectral imaging and cross-polarized flash to generate maps of pigmentation, UV spots, porphyrin fluorescence, wrinkles, redness, and pore distribution.[9] These systems are used to plan cosmetic treatments... photofacials, retinoids, aesthetic injectables, resurfacing procedures... and to show patients surface-level change over time. They quantify what a cosmetic practitioner is already trained to assess visually. They are not designed to, and are not cleared to, diagnose skin cancer.

Between these ends, teledermatology (store-and-forward and live video consultation) is increasingly how dermatologic care reaches patients outside urban specialist clinics. Store-and-forward teledermatology, where a primary care clinician sends photographs of a lesion for a dermatologist to review, has been shown to be diagnostically comparable to in-person evaluation in multiple studies.[10][11]

Diagnostic vs. cosmetic, and why this matters.

The single most important thing a reader of this site should take away is the difference between a diagnostic tool and a cosmetic one.

A diagnostic tool is evaluated, cleared, and used in a regulatory and clinical framework designed to help a physician decide whether a skin lesion is likely benign or whether it needs to be biopsied. It carries a sensitivity, a specificity, a negative predictive value, and an intended use statement. It is operated by, or in collaboration with, a licensed clinician. Its performance is published, peer-reviewed, and audited over time.[12][13]

A cosmetic skin analysis system is evaluated against a different target. It quantifies surface and sub-surface features that are relevant to cosmetic planning. Its purpose is to help a clinician and a patient agree on an aesthetic treatment plan and to document change over time. It is not designed to diagnose skin cancer, and a normal cosmetic analysis tells you nothing about whether a mole on your back is a melanoma.[9]

Both are legitimate tools in their own contexts. The error... and it is a real error, made often in consumer marketing... is to let the language of the aesthetic category drift into the language of diagnosis. "Our scan can detect skin conditions." "Our scanner sees beneath the skin." "AI-powered skin analysis." That language sounds clinical. When it is applied to a cosmetic tool, it misleads a reader into thinking a cosmetic scanner has ruled out something it was never designed to evaluate.

The rest of this site is organized around holding that line.

What you will find here.

Two pages beyond this one. The Research page is a cited synthesis of the evidence on dermoscopy, total body photography and sequential digital dermoscopy, FDA-cleared AI-assisted devices (DermaSensor and SciBase Nevisense), teledermatology, VISIA and aesthetic skin analysis, spectral and hyperspectral imaging, 3D skin mapping, and the meaningful line between screening and diagnosis. The About page explains the site's editorial mission, the doctor behind it, and how to get in touch for clinical questions.

This site does not sell anything, collect email addresses, or operate a practitioner directory. If you are looking for a practitioner with a DermaSensor, the block below will take you to the DermaSensor practitioner lookup.

Looking for a practitioner with DermaSensor?

DermaSensor maintains a practitioner finder that lists clinicians who use the device in their practice. If you have a skin lesion a clinician has flagged as suspicious and you want to find a practitioner near you who offers a DermaSensor scan as part of their workup, you can search DermaSensor's own directory.

Find a DermaSensor practitioner on dermasensor.com →

dermascanguide.com does not operate or maintain this directory. The DermaSensor practitioner finder is run by DermaSensor, Inc.

A reminder before you go any further. AI-based skin scanning apps and devices are adjuncts to clinical evaluation, not substitutes for it. A negative scan does not rule out melanoma. Aesthetic skin analysis systems like VISIA measure surface and sub-surface features for cosmetic planning and are not diagnostic. If you have a lesion that has changed in color, shape, or size, is bleeding, is itching or painful, or is otherwise concerning, see a licensed dermatologist.